Cargando…

How does external reference pricing work in developing countries: evidence from Iran

Introduction: Governments apply different pricing policies to ensure public accessibility, availability, and affordability of medicines. In this way, external reference pricing (ERP) because of its easy implementation is used widely across countries. However, ERP is completely path dependent, and it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Babaie, Fatemeh, Motevalli, Mohammad Hossein, Mehralian, Gholamhossein, Peiravian, Farzad, Yousefi, Nazila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319150/ https://www.ncbi.nlm.nih.gov/pubmed/37408767 http://dx.doi.org/10.3389/fphar.2023.1034229

Ejemplares similares

Perceptions, experiences and expectations of physicians regarding the role of pharmacists in low-income and middle-income countries: the case of Tehran hospital settings
por: Alipour, Fatemeh, et al.
Publicado: (2018)

Public and decision-maker stated preferences for pharmaceutical subsidy decisions in Iran: an application of the discrete choice experiment
por: Afsharmanesh, Gita, et al.
Publicado: (2021)

Investigation the determinants of pharmaceutical expenditure share of GDP in Iran and selected OECD countries
por: Kadkhodamanesh, Azin, et al.
Publicado: (2021)

Distributor– Retailer Interface in Pharmaceutical Supply Chain: Service Quality Measurement Scale
por: Mehralian, Gholamhossein, et al.
Publicado: (2016)

Attributes Development for Pharmaceutical Subsidization: A Qualitative Study
por: Afsharmanesh, Gita, et al.
Publicado: (2020)

An application of multi-criteria decision-making approach to sustainable drug shortages management: evidence from a developing country
por: Moosivand, Asiye, et al.
Publicado: (2021)

Impact of the Trade-Related Aspect of Intellectual Property Rights Agreement on Pharmaceutical Industry in Developing Countries: A Scoping Review
por: Fathi, Mahdieh, et al.
Publicado: (2021)

The Effect of Organizational Resilience and Strategic Foresight on Firm Performance: Competitive Advantage as Mediating Variable
por: Fathi, Mahdieh, et al.
Publicado: (2021)

New Product Development in the Pharmaceutical Industry: Evidence from a generic market
por: Yousefi, Nazila, et al.
Publicado: (2017)

Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country
por: Fathi, Mahdieh, et al.
Publicado: (2023)

Country Pharmaceutical Situation on Access, Quality, and Rational Use of Medicines: An Evidence from a middle-income country
por: Minaei, Hossein, et al.
Publicado: (2019)

Teriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis
por: Taheri, Saeed, et al.
Publicado: (2019)

Knowledge, Attitude and Practice of Pharmacists regarding Dietary Supplements : A Community Pharmacy- based survey in Tehran
por: Mehralian, Gholamhossein, et al.
Publicado: (2014)

How Do Iranian Stakeholders Think About Pharmaceutical Managed Entry Agreements?
por: Shobeiri, Nikta, et al.
Publicado: (2022)

Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications
por: Incze, András, et al.
Publicado: (2022)

Exploring health seeking behaviors for common cold management
por: Keshvari, Negin, et al.
Publicado: (2023)

Diagnosing Malaria Cases Referred to the Malaria Reference Laboratory in Tehran University of Medical Science, Iran
por: NATEGHPOUR, Mehdi, et al.
Publicado: (2015)

How Much Iranian Parents Know of and How Well They Practice Regarding Antibiotics?
por: Sharif, Zahra, et al.
Publicado: (2021)

An investigation into the pharmaceutical advertising in Iranian medical journals
por: Yousefi, Nazila, et al.
Publicado: (2022)

An application of analytic network process model in supporting decision making to address pharmaceutical shortage
por: Zarei, Leila, et al.
Publicado: (2020)

Medication Adherence and Health Literacy in Patients with Heart Failure: A Cross-Sectional Survey in Iran
por: Rezaei, Soheila, et al.
Publicado: (2022)

Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries
por: Kawalec, Paweł, et al.
Publicado: (2017)

Out-of-pocket payments for treatment of COVID-19 in Iran
por: Yusefi, Ali Reza, et al.
Publicado: (2022)

Resource allocation and purchasing arrangements to improve accessibility of medicines: Evidence from Iran
por: Bastani, Peivand, et al.
Publicado: (2015)

Resilience level and its relationship with hypochondriasis in nurses working in COVID-19 reference hospitals
por: Yusefi, Ali Reza, et al.
Publicado: (2021)

Efficacy and Safety of Dulaglutide Compared to Liraglutide: A Systematic Review and Meta-analysis in Patients with Type 2 Diabetes Mellitus
por: Taheri, Saeed, et al.
Publicado: (2019)

Overview of external reference pricing systems in Europe
por: Rémuzat, Cécile, et al.
Publicado: (2015)

The Structure of the World Pharmaceutical Market: Prioritizing Iran’s Target Export Markets
por: Shabaninejad, Hosein, et al.
Publicado: (2019)

Health literacy and medication adherence in psoriasis patients: a survey in Iran
por: Avazeh, Yasaman, et al.
Publicado: (2022)

Does external reference pricing deliver what it promises? Evidence on its impact at national level
por: Kanavos, Panos, et al.
Publicado: (2019)

Burnout among nurses working in medical and educational centers in Shahrekord, Iran
por: Moghaddasi, Jaefar, et al.
Publicado: (2013)

Human Resource Management Challenges to Develop Pharmaceutical Industry: Evidence from Developing Countries
por: Babapour, Jafar, et al.
Publicado: (2018)

Hospital management by health services management graduates: the change paradigm in Iran
por: Bastani, Peivand, et al.
Publicado: (2021)

Impact of External Price Referencing on Medicine Prices – A Price Comparison Among 14 European Countries
por: Leopold, Christine, et al.
Publicado: (2012)

The impact of external reference pricing on pharmaceutical costs and market dynamics
por: Voehler, Dominic, et al.
Publicado: (2023)

The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2019)

Development of an Integrated Performance Measurement (PM) Model for Pharmaceutical Industry
por: Shabaninejad, Hosein, et al.
Publicado: (2014)

Challenge of Politico-Economic Sanctions on Pharmaceutical Procurement in Iran: A Qualitative Study
por: Bastani, Peivand, et al.
Publicado: (2022)

The Scarce Drugs Allocation Indicators in Iran: A Fuzzy Delphi Method Based Consensus
por: Zarei, Leila, et al.
Publicado: (2019)

The Crux of the Medicine Prices' Controversy in Pakistan
por: Lee, Kah S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ljfr436f179jf0581t1g9b52oj